Medicina intensiva最新文献

英文中文

Metastatic abscessed lymphadenopathy as the origin of septic shock.

Medicina intensiva

Pub Date : 2025-02-24 DOI: 10.1016/j.medine.2025.502127

Enrique Alfonso Aguilar Valero, Ana María Vela Colmenero, Rosa María Vela Colmenero

引用次数: 0

Monitoring through electrical impedance tomography in pediatric ECMO. 通过电阻抗断层扫描监测儿科 ECMO。

Medicina intensiva

Pub Date : 2025-02-24 DOI: 10.1016/j.medine.2025.502155

Gabriel Appendino, Fernando Paziencia, Carlos Lovesio

引用次数: 0

Stroke in the pediatric intensive care unit.

Medicina intensiva

Pub Date : 2025-02-24 DOI: 10.1016/j.medine.2025.502154

Javier Zorrilla Abad, Débora Sanz Álvarez, Gema Manrique Martín, Laura Herrera Castillo, Jesús López-Herce Cid

Objectives: To analyze the frequency, causes, risk factors, mortality and sequelae of stroke in children admitted to the pediatric intensive care unit (PICU).

Design: Single-center retrospective observational study based on a prospective database.

Setting: Pediatric intensive care unit.

Patients: Children between one month and eighteen years of age admitted to the PICU and diagnosed with stroke were included.

Main variables of interest: Epidemiological, clinical, diagnostic and treatment data, sequelae and mortality were recorded.

Interventions: None.

Results: 46 patients were studied, of whom 29 (63%) had an ischemic stroke, 14 (30.4%) a hemorrhagic stroke, 1 (2.2%) venous sinus thrombosis and 2 (4.3%) mixed stroke. 11 patients (23.9%) had heart disease and 7 (15.2%) were treated with extracorporeal membrane oxygenation (ECMO) or ventricular assist. 8.6% of patients were treated with fibrinolysis or thrombectomy. 9 patients (19.6%) died. Patients with heart disease and those treated with ECMO had a higher mortality rate. 23 children, 62.1% of survivors, suffered sequelae at discharge. The most frequent sequelae were hemiparesis. Sequelae were significantly more frequent in patients who presented with motor symptoms (76.2%) (p < 0.001).

Conclusions: The frequency of ischemic stroke in pediatric patients is higher than that of hemorrhagic stroke. Pediatric patients who suffer a stroke have a high mortality rate and a high rate of sequelae. Patients with heart disease and those treated with ECMO are those who present stroke most frequently and have a higher mortality rate.

{"title":"Stroke in the pediatric intensive care unit.","authors":"Javier Zorrilla Abad, Débora Sanz Álvarez, Gema Manrique Martín, Laura Herrera Castillo, Jesús López-Herce Cid","doi":"10.1016/j.medine.2025.502154","DOIUrl":"https://doi.org/10.1016/j.medine.2025.502154","url":null,"abstract":"Objectives: To analyze the frequency, causes, risk factors, mortality and sequelae of stroke in children admitted to the pediatric intensive care unit (PICU).Design: Single-center retrospective observational study based on a prospective database.Setting: Pediatric intensive care unit.Patients: Children between one month and eighteen years of age admitted to the PICU and diagnosed with stroke were included.Main variables of interest: Epidemiological, clinical, diagnostic and treatment data, sequelae and mortality were recorded.Interventions: None.Results: 46 patients were studied, of whom 29 (63%) had an ischemic stroke, 14 (30.4%) a hemorrhagic stroke, 1 (2.2%) venous sinus thrombosis and 2 (4.3%) mixed stroke. 11 patients (23.9%) had heart disease and 7 (15.2%) were treated with extracorporeal membrane oxygenation (ECMO) or ventricular assist. 8.6% of patients were treated with fibrinolysis or thrombectomy. 9 patients (19.6%) died. Patients with heart disease and those treated with ECMO had a higher mortality rate. 23 children, 62.1% of survivors, suffered sequelae at discharge. The most frequent sequelae were hemiparesis. Sequelae were significantly more frequent in patients who presented with motor symptoms (76.2%) (p < 0.001).Conclusions: The frequency of ischemic stroke in pediatric patients is higher than that of hemorrhagic stroke. Pediatric patients who suffer a stroke have a high mortality rate and a high rate of sequelae. Patients with heart disease and those treated with ECMO are those who present stroke most frequently and have a higher mortality rate.","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":" ","pages":"502154"},"PeriodicalIF":0.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143506675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Is it time to measure disease-free survival in critical oncology population? 现在是衡量关键肿瘤人群无病生存期的时候了吗？

Medicina intensiva

Pub Date : 2025-02-24 DOI: 10.1016/j.medine.2025.502157

Elena Cuenca-Fito, Eric Mayor-Vázquez

引用次数: 0

Diagnosis of colitis by ultrasound in an Intensive Care Unit.

Medicina intensiva

Pub Date : 2025-02-21 DOI: 10.1016/j.medine.2024.502115

C M Marín Marín, P García Moreno, R Vicho Pereira

引用次数: 0

What predictive scores don't talk about.

Medicina intensiva

Pub Date : 2025-02-19 DOI: 10.1016/j.medine.2025.502158

Marcos Valiente Fernández, Cristina Serrano Gómez, Amanda Lesmes González de Aledo, Isaías Martín Badía

引用次数: 0

Changes in the stress hormone cortisol during intensive care unit stay as a predictor of objective cognition at discharge.

Medicina intensiva

Pub Date : 2025-02-18 DOI: 10.1016/j.medine.2025.502166

Guillem Navarra-Ventura, Marta Godoy-González, Lluís Blanch, Josefina López-Aguilar, Sol Fernández-Gonzalo

引用次数: 0

Acute aortic syndrome and cardiogenic shock, beyond radiological diagnosis.

Medicina intensiva

Pub Date : 2025-02-17 DOI: 10.1016/j.medine.2025.502124

Hala El Haddad, Isabel Espinosa Rueda, Nora Palomo-López

引用次数: 0

Association between lactate-to-albumin ratio and all-cause mortality in cirrhosis patients: Analysis of the MIMIC-IV database.

Medicina intensiva

Pub Date : 2025-02-15 DOI: 10.1016/j.medine.2025.502145

Yusong Ye, Shu Huang, Xiaohong Wang, Wensen Ren, Xiaomin Shi, Sha Liu, Wei Zhang, Lei Shi, Muhan Lü, Xiaowei Tang

Objective: This study evaluates the predictive value of the lactate/albumin ratio (LAR) for all-cause mortality in cirrhosis patients.

Design: Retrospective observational study.

Setting: Intensive care unit (ICU).

Patients or participants: 626 first-time ICU-admitted cirrhosis patients in the USA (MIMIC-IV v2.2).

Interventions: None.

Main variables of interest: LAR index, 28-day, and 90-day all-cause mortality.

Results: Of 626 patients (60.86% male), 27.80% and 39.14% died within 28 and 90 days, respectively. Multivariate Cox analysis showed a significant association between higher LAR and mortality. Adjusted for confounders, elevated LAR increased the 28-day mortality risk [HR: 1.31 (1.21-1.42), P < 0.001]. A restricted cubic spline analysis revealed non-linear relationships between LAR and mortality. For 28-day mortality, the inflection point was 1.583: below this, HR was 2.29 (95% CI: 1.61-3.27, P < 0.001); above, HR was 1.16 (95% CI: 1.02-1.31, P = 0.021; P = 0.002). For 90-day mortality, the inflection point was 1.423: below, HR was 1.60 (95% CI: 1.04-2.47, P = 0.033); above, HR was 0.94 (95% CI: 0.75-1.16, P = 0.542; P = 0.012).

Conclusions: LAR predicts 28-day and 90-day mortality with a segmented effect. An LAR ≥1.583 signals high 28-day mortality risk, necessitating intensified monitoring and potential ICU admission. For 90-day mortality, LAR near 1.423 serves as an early warning for high-risk patients and guides interventions. Continuous LAR monitoring aids management, but prospective studies are needed to confirm clinical utility.

{"title":"Association between lactate-to-albumin ratio and all-cause mortality in cirrhosis patients: Analysis of the MIMIC-IV database.","authors":"Yusong Ye, Shu Huang, Xiaohong Wang, Wensen Ren, Xiaomin Shi, Sha Liu, Wei Zhang, Lei Shi, Muhan Lü, Xiaowei Tang","doi":"10.1016/j.medine.2025.502145","DOIUrl":"https://doi.org/10.1016/j.medine.2025.502145","url":null,"abstract":"Objective: This study evaluates the predictive value of the lactate/albumin ratio (LAR) for all-cause mortality in cirrhosis patients.Design: Retrospective observational study.Setting: Intensive care unit (ICU).Patients or participants: 626 first-time ICU-admitted cirrhosis patients in the USA (MIMIC-IV v2.2).Interventions: None.Main variables of interest: LAR index, 28-day, and 90-day all-cause mortality.Results: Of 626 patients (60.86% male), 27.80% and 39.14% died within 28 and 90 days, respectively. Multivariate Cox analysis showed a significant association between higher LAR and mortality. Adjusted for confounders, elevated LAR increased the 28-day mortality risk [HR: 1.31 (1.21-1.42), P < 0.001]. A restricted cubic spline analysis revealed non-linear relationships between LAR and mortality. For 28-day mortality, the inflection point was 1.583: below this, HR was 2.29 (95% CI: 1.61-3.27, P < 0.001); above, HR was 1.16 (95% CI: 1.02-1.31, P = 0.021; P = 0.002). For 90-day mortality, the inflection point was 1.423: below, HR was 1.60 (95% CI: 1.04-2.47, P = 0.033); above, HR was 0.94 (95% CI: 0.75-1.16, P = 0.542; P = 0.012).Conclusions: LAR predicts 28-day and 90-day mortality with a segmented effect. An LAR ≥1.583 signals high 28-day mortality risk, necessitating intensified monitoring and potential ICU admission. For 90-day mortality, LAR near 1.423 serves as an early warning for high-risk patients and guides interventions. Continuous LAR monitoring aids management, but prospective studies are needed to confirm clinical utility.","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":" ","pages":"502145"},"PeriodicalIF":0.0,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Giant ventricular pseudoaneurysm after acute myocardial infarction.

Medicina intensiva

Pub Date : 2025-02-11 DOI: 10.1016/j.medine.2025.502120

Javier Ceña Carazo, Marlene Feo González, Adolfo Iñiguez de Diego

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Medicina intensiva

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀